Internal Medicine, Nephrology · Statesville, NC
NPI
1225059017
Since 2006
Specialty
Internal Medicine, Nephrology
Code 207RN0300X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
2603 Davie Ave
Statesville, NC, 28625
Phone (704) 873-6515
Groups this clinician bills Medicare through
Medicare paid, 2024
$146K
1,587 services
Medicare patients, 2024
348
Average age 75
Drug cost, 2024
$398K
2,961 prescriptions
Company payments, 2025
$549
From 11 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Wolfgang E Lohrmann was code 99232 (hospital e&m - subsequent), 496 times for 127 patients. In total Wolfgang E Lohrmann billed 1,587 services in 26 codes, and Medicare paid $146K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2013-04-25.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99232 Hospital E&M - Subsequent | Facility | 496 | 127 | $54.59 | $27K |
| 99214 Office E&M - Established | Office | 262 | 137 | $85.15 | $22K |
| 99233 Hospital E&M - Subsequent | Facility | 234 | 75 | $82.67 | $19K |
| 90960 ESRD Related Services (not dialysis) | Office | 102 | 17 | $246.03 | $25K |
| 99213 Office E&M - Established | Office | 96 | 82 | $55.87 | $5,363 |
| 99223 Hospital E&M - Initial | Facility | 80 | 76 | $121.44 | $9,715 |
| 99222 Hospital E&M - Initial | Facility | 67 | 58 | $88.79 | $5,949 |
| 90935 Hemodialysis | Facility | 58 | 20 | $49.58 | $2,875 |
| 99291 Critical Care E&M | Facility | 39 | 12 | $148.99 | $5,811 |
| 90961 ESRD Related Services (not dialysis) | Office | 34 | 12 | $206.06 | $7,006 |
| 99204 Office E&M - New | Office | 14 | 14 | $117.35 | $1,643 |
| 99203 Office E&M - New | Office | 13 | 13 | $71.87 | $934 |
By year: 2022 $189K for 1,745 services; 2023 $127K for 1,207 services; 2024 $146K for 1,587 services.
Medicare prescription drug claims, 2024
In 2024, the drug Wolfgang E Lohrmann prescribed most often to Medicare patients was Amlodipine Besylate, with 189 prescriptions and refills. In total Wolfgang E Lohrmann wrote 2,961 Medicare prescriptions that cost $398K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Amlodipine Besylate Generic | 189 | 350 | 46 | $981 |
| Farxiga Dapagliflozin Propanediol | 172 | 222 | 33 | $125K |
| Sps Sodium Polystyrene Sulfon/Sorb | 117 | 123 | 37 | $24K |
| Lisinopril Generic | 97 | 202 | 33 | $340 |
| Prednisone Generic | 97 | 121 | 24 | $422 |
| Torsemide Generic | 92 | 149 | 24 | $1,489 |
| Furosemide Generic | 92 | 202 | 29 | $540 |
| Carvedilol Generic | 86 | 146 | 20 | $365 |
| Tamsulosin Hcl Generic | 77 | 120 | 17 | $415 |
| Potassium Chloride Generic | 68 | 114 | 18 | $814 |
| Gabapentin Generic | 65 | 92 | 14 | $830 |
| Sevelamer Carbonate Generic | 65 | 107 | 22 | $9,590 |
| Tramadol Hcl Generic | 60 | 60 | 13 | $351 |
| Calcium Acetate Generic | 58 | 78 | 18 | $2,755 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 57 | 72 | Under 11 | $260 |
Brand drugs: 420 claims; generic drugs: 2,524 claims; opioid claims: 161.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Wolfgang E Lohrmann $549 ($549 in general payments such as food, travel and fees) from 11 companies. The largest payer was Calliditas Therapeutics US Inc. with $104.
| Company | Payments | Amount |
|---|---|---|
| Calliditas Therapeutics US Inc. | 4 | $104 |
| Novartis Pharmaceuticals Corporation NVS | 4 | $96.29 |
| Ardelyx, Inc. ARDX | 3 | $77.07 |
| Novo Nordisk Inc NVO | 3 | $71.41 |
| AstraZeneca Pharmaceuticals LP AZN | 3 | $53.36 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 2 | $35.27 |
| Mallinckrodt Hospital Products Inc. | 1 | $34.91 |
| Amgen Inc. AMGN | 1 | $24.16 |
| Apellis Pharmaceuticals, Inc. APLS | 1 | $21.99 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 1 | $16.23 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.